Neuropharmacology is the branch of pharmacology that studies drugs and their effects on the nervous system. This includes the study of neurotransmitters, which are chemical messengers in nerve cells, as well as the drugs that act on them or the neurotransmitter receptors. Neuropharmacology overlaps significantly with psychopharmacology, which is the study of how drugs affect behaviour and mood. While psychopharmacology can be considered a subfield of neuropharmacology, it also has its own theories and focus. The main goals of neuropharmacology are to understand how drugs interact with the nervous system to produce their effects, and to determine which drugs can be used to treat specific illnesses or disorders. This involves studying the effects of specific drugs on nerve cells and their receptors, as well as how drugs interact with other cellular components. Neuropharmacologists also study drug metabolism in the body, as well as interactions between the environment and drugs. Neuropharmacology is important for both the treatment of diseases and disorders of the nervous system as well as for understanding normal brain function and development. For example, neuropharmacologists can use drugs to reduce or eliminate pain, reduce seizures, improve breathing and even restore lost nerve function. Neuropharmacology is also important for understanding the effects of drugs on the brain, such as how they affect memory, concentration, learning and emotions. Different classes of drugs have specific mechanisms of action. For example, antidepressants work by changing the levels of neurotransmitters such as serotonin and norepinephrine in the brain, while cannabinoids act on cannabinoid receptors to produce their effects. Neuropharmacologists must also consider factors such as drug interactions and potential side effects. In conclusion, neuropharmacology is an important field that studies the effects of drugs on the nervous system, both in terms of disease and health. By understanding how drugs interact with the nervous system, neuropharmacologists are able to develop drugs to treat a variety of conditions, as well as to understand normal brain functions.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States